DELI

Porton Gets Improved In The 2023 S&P Global ESG Score Porton Gets Improved In The 2023 S&P Global ESG Score
20.09.2023

Porton Gets Improved In The 2023 S&P Global ESG Score

Porton Gets Improved In The 2023 S&P Global ESG Score

Porton Pharma Solutions Ltd. is glad to announce that it scored 38 (out of 100) in the 2023 S&P Global Corporate Sustainability Assessment reflecting an improvement of 9 points based on the 2023 methodology over the last year, where scores in all the three dimensions getting improved and exceeding the industry average. (CSA Score as of 25/08/2023).

Porton Gets Improved In The 2023 S&P Global ESG Score

Porton continues to gain ground in its environmental, social, and governance initiatives. In 2023, Porton establishes a top-down ESG governance structure, which includes Board Strategy and ESG Committee, ESG Executive Committee and ESG Working Team, to ensure the implementation of responsibilities and management measures. Meanwhile, Porton has identified 19 ESG high material issues and will further address and respond to these issues and enhance ESG performance.

Porton Gets Improved In The 2023 S&P Global ESG Score

For Porton, improving ESG governance and performance is a continuous evolutionary process. We will always be committed to cooperating with all stakeholders to achieve sustainable development.

DELI

Porton Gets Improved In The 2023 S&P Global ESG Score Porton Gets Improved In The 2023 S&P Global ESG Score
Porton to Showcase Cutting-edge Innovations at BIO-Europe Spring 2025 Join Porton at Leading Industry Conferences to Explore Innovations and Network with Experts Porton Has Been Invited to the China–Slovenia Business and Investment Forum and Had a Friendly Meeting with Slovenian Officials. Porton’s New Modality Capacity Upgrade Ceremony Successfully Held Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar Driving innovation and excellence in the CDMO industry, Porton Pharma Solutions 2024 CPHI Europe Review Technical Enability | Porton’s Team of Global Chemical Engineering and Technology Published Breakthrough Results in Crystal Growth & Design and reported them at the 2024 Crystal Engineering Gordon Research Conference Keep hope alive! We invite you to stay tuned to DMD Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals Porton Will Be Participating In Biotech Outsourcing Strategies Events This June Proton At CPhI North America Again Porton 2023 ESG Report Upcoming Porton Shows In Europe And The USA:Shaping Our Future Together Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development Join Our Founder And CEO @ DCAT Week Porton Pharma Solutions Joined The SBTi To Drive Climate Action Farewell To 2023, And WE Are Sailing Forward To 2024 The Pharma Crystallization Summit (PCS) Is Held Annually To Bring Together Developers Of New Medicines With Crystallization Challenges And The Crystallization Experts (Solution Providers) In The Industry And Academia. Porton Gets Improved In The 2023 S&P Global ESG Score Porton Pharma Solutions Announces New Flagship Facility Offering Integrated API Crystallization And Drug Product Development Services Pharma Digital Intelligence Summit Will Be Held On 5th, September, 2023 [Important Notice] Porton Announcement Regarding The Change Of Email Domain Porton Unveils Its Small Molecule Platform Headquarters In Shanghai PORTON Starts Construction Of Its Facility For Antibodies And ADCs In Shanghai Porton At DCAT Week 2023: A Highly Successful And Strategic Event Porton Released 2022 CSR Report Porton Delivers Strong 2022 Performance With 127% Sales Growth Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score
Novice

Razkriti vpogledi: poglobite se v naše globalno središče novic!

22.05.2024

Otvoritev sodobnih raziskovalno-razvojnih laboratorijev podjetja Porton za področje farmacevtskih učinkovin, malih molekul v Mengšu

  • Slovesna otvoritev sodobnih raziskovalno-razvojnih laboratorijev za farmacevtske učinkovine, male molekule podjetja Porton v Mengšu.

  • Donacija 20.000,00 EUR Občini Mengeš za obnovo poplavljenega vrtca.

  • Nova delovna mesta in nadaljnja rast na področju farmacevtskih učinkovin, malih molekul v Mengšu

Preberi novico

Cookie settings

Your current status

Show details